Sex differences in the prevalence of Helicobacter pylori infection: an individual participant data pooled analysis (StoP Project).


Journal

European journal of gastroenterology & hepatology
ISSN: 1473-5687
Titre abrégé: Eur J Gastroenterol Hepatol
Pays: England
ID NLM: 9000874

Informations de publication

Date de publication:
05 2019
Historique:
pubmed: 7 3 2019
medline: 6 8 2019
entrez: 7 3 2019
Statut: ppublish

Résumé

Helicobacter pylori (H. pylori) infection is more frequent among men, though the magnitude of the association might be inaccurate due to potential misclassification of lifetime infection and publication bias. Moreover, infection is common, and most studies are cross-sectional. Thus, prevalence ratios (PRs) may be easier to interpret than odds ratios (ORs). The aim of this study was to quantify the association between sex and H. pylori infection using controls from 14 studies from the Stomach Cancer Pooling (StoP) Project. H. pylori infection was defined based on IgG serum antibody titers or multiplex serology. Participants were also classified as infected if gastric atrophy was present, based on histological examination or serum pepsinogen (PG) levels (PG I≤70 and PG I/II ratio≤3). Summary ORs and PRs, adjusted for age, social class and smoking, and corresponding 95% confidence intervals (CIs), were estimated through random-effects meta-analysis. Men had significantly higher OR (OR: 1.33, 95% CI: 1.04-1.70) and PR (PR: 1.05, 95% CI: 1.00-1.10) of infection, with stronger associations among hospital-based or older controls. Results were similar when considering the presence of gastric atrophy to define infection status, particularly among participants older than 65 years. This collaborative pooled-analysis supports an independent effect of sex on the prevalence of H. pylori infection, while minimizing misclassification of lifetime infection status and publication bias.

Sections du résumé

BACKGROUND
Helicobacter pylori (H. pylori) infection is more frequent among men, though the magnitude of the association might be inaccurate due to potential misclassification of lifetime infection and publication bias. Moreover, infection is common, and most studies are cross-sectional. Thus, prevalence ratios (PRs) may be easier to interpret than odds ratios (ORs).
AIM
The aim of this study was to quantify the association between sex and H. pylori infection using controls from 14 studies from the Stomach Cancer Pooling (StoP) Project.
PARTICIPANTS AND METHODS
H. pylori infection was defined based on IgG serum antibody titers or multiplex serology. Participants were also classified as infected if gastric atrophy was present, based on histological examination or serum pepsinogen (PG) levels (PG I≤70 and PG I/II ratio≤3). Summary ORs and PRs, adjusted for age, social class and smoking, and corresponding 95% confidence intervals (CIs), were estimated through random-effects meta-analysis.
RESULTS
Men had significantly higher OR (OR: 1.33, 95% CI: 1.04-1.70) and PR (PR: 1.05, 95% CI: 1.00-1.10) of infection, with stronger associations among hospital-based or older controls. Results were similar when considering the presence of gastric atrophy to define infection status, particularly among participants older than 65 years.
CONCLUSION
This collaborative pooled-analysis supports an independent effect of sex on the prevalence of H. pylori infection, while minimizing misclassification of lifetime infection status and publication bias.

Identifiants

pubmed: 30839435
doi: 10.1097/MEG.0000000000001389
doi:

Substances chimiques

Antibodies, Bacterial 0
Immunoglobulin G 0

Types de publication

Journal Article Meta-Analysis

Langues

eng

Pagination

593-598

Commentaires et corrections

Type : CommentIn

Auteurs

Ana Ferro (A)

EPIUnit - Instituto de Saúde Pública.

Samantha Morais (S)

EPIUnit - Instituto de Saúde Pública.

Claudio Pelucchi (C)

Department of Clinical Sciences and Community Health.

Trinidad Dierssen-Sotos (T)

Universidad de Cantabria - IDIVAL, Santander.
CIBER Epidemiología y Salud Pública, Madrid.

Vicente Martín (V)

CIBER Epidemiología y Salud Pública, Madrid.
Research Group on Gene-Environment Interactions and Health, University of León, Spain.

Lizbeth López-Carrillo (L)

Instituto Nacional de Salud Pública, Morelos.

Reza Malekzadeh (R)

Digestive Oncology Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran.
Department of Biostatistics, Yale School of Public Health, Yale School of Medicine, New Haven, Connecticut, USA.

Shoichiro Tsugane (S)

Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, Japan.

Gerson S Hamada (GS)

Nikkei Disease Prevention Center, São Paulo, Brazil.

Akihisa Hidaka (A)

Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, Japan.

Raul U Hernández-Ramírez (RU)

Instituto Nacional de Salud Pública, Morelos.

Malaquias López-Cervantes (M)

Facultad de Medicina, UNAM, Coyoacán, Mexico.

David Zaridze (D)

Department of Epidemiology and Prevention, Russian N.N. Blokhin Cancer Research Center, Moscow, Russia.

Dmitry Maximovitch (D)

Department of Epidemiology and Prevention, Russian N.N. Blokhin Cancer Research Center, Moscow, Russia.

Farhad Pourfarzi (F)

Digestive Oncology Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran.
Digestive Disease Research Center, Ardabil University of Medical Sciences, Ardabil, Iran.

Zuo-Feng Zhang (ZF)

Department of Epidemiology, UCLA Fielding School of Public Health and Jonsson Comprehensive Cancer Center, Los Angeles, California.

Guo-Pei Yu (GP)

Medical Informatics Center, Peking University, Peking, China.

Mohammadreza Pakseresht (M)

Digestive Oncology Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran.
Department of Agricultural, Food and Nutritional Sciences, University of Alberta, Edmonton, Alberta, Canada.
Nutritional Epidemiology Group, Centre for Epidemiology and Biostatistics, University of Leeds, Leeds, UK.

Weimin Ye (W)

Center of Public Health Sciences, Faculty of Medicine, University of Iceland, Reykjavík, Iceland.

Amelie Plymoth (A)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Marcis Leja (M)

Institute of Clinical and Preventive Medicine and Faculty of Medicine, University of Latvia, Riga, Latvia.

Evita Gasenko (E)

Institute of Clinical and Preventive Medicine and Faculty of Medicine, University of Latvia, Riga, Latvia.

Mohammad H Derakhshan (MH)

Digestive Oncology Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran.
Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

Eva Negri (E)

Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.

Carlo La Vecchia (C)

Department of Clinical Sciences and Community Health.

Bárbara Peleteiro (B)

EPIUnit - Instituto de Saúde Pública.
Departamento de Ciências da Saúde Pública e Forenses e Educação Médica, Faculdade de Medicina, Universidade do Porto, Porto, Portugal.

Nuno Lunet (N)

EPIUnit - Instituto de Saúde Pública.
Departamento de Ciências da Saúde Pública e Forenses e Educação Médica, Faculdade de Medicina, Universidade do Porto, Porto, Portugal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH